HOME

ABOUT US

• •  Management
• •  Board of Directors
  •  Compliance

PRODUCT

• •  ADCETRIS

PIPELINE

• •  Brentuximab Vedotin (SGN-35)
• •  SGN-75
• •  ASG-5ME
• •  ASG-22ME
• •  SGN-CD19A
• •  Research
• •  Medical Information

TECHNOLOGY

• •  ADC Technology
• •  SEA Technology

CLINICAL TRIALS

• •  Brentuximab Vedotin (SGN-35)
• •  SGN-75
• •  ASG-5ME
• •  ASG-22ME

• •  Hodgkin Lymphoma
• •  Non-Hodgkin Lymphoma
• •  Solid Tumors

INVESTORS & NEWS

• •  Press Releases
• •  Stock Performance
• •  SEC Filings
• •  Webcasts & Events
• •  Scientific Publications
• •  Corporate Governance
• •  Analyst Coverage
• •  Financial Reports
• •  Investor FAQ
• •  Information Request

CAREERS

• •  Benefits
• •  Living in the Area
• •  Vision/Values
• •  Job Opportunities

GLOSSARY

SITEMAP

CONTACT